Catalyst Wire Dossier Catalyst Wire Dossier

Apixaban

apixaban · Bristol Myers Squibb and Pfizer
Drug timelines are a Plus or Pro feature.

103 regulatory and trial events tracked for Apixaban, covering 2011-10-25 to 2026-06-24. Get the full timeline:

Most recent: Clinical Trial Results: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism [Phase 4]

See pricing